Hori, K.; Uchida, T. Tau protein kinase II is involved in the regulation from the typical phosphorylation state of tau protein. J. Neurochem. 1993, 60, 461?68. 129. Imahori, K.; Hoshi, M.; Ishiguro, K.; Sato, K.; Takahashi, M.; Shiurba. R.; Yamaguchi. H.; Takashima, A.; Uchida, T. Feasible function of tau protein kinases in pathogenesis of Alzheimer illness. Neurobiol. Aging 1998, 19, S93 98. 130. Rank, K.B.; Pauley, A.M.; Bhattacharya, K.; Wang, Z.; Evans, D.B.; Fleck, T.J.; Johnston, J.A.; Sharma, S.K. Direct interaction of soluble human recombinant tau protein with Abeta 1?two results in tau aggregation and hyperphosphorylation by tau protein kinase II. FEBS Lett. 2002, 514, 263?68. 131. Takashima, A.; Honda, T.; Yasutake, K.; Michel, G.; Murayama, O.; Murayama, M.; Ishiguro, K.; Yamaguchi, H. Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25?5) enhances phosphorylation of tau in hippocampal neurons.1053656-76-0 Purity Neurosci. Res. 1998, 31, 317?23. 132. Braithwaite, S.P.; Stock, J.B.; Lombroso, P.J.; Nairn, A.C. Protein phosphatases and Alzheimer’s disease. Prog. Mol. Biol. Transl. Sci. 2012, 106, 343?79. 133. Garver, T.D.; Kincaid, R.L.; Conn, R.A.; Billingsley, M.L. Reduction of calcineurin activity in brain by antisense oligonucleotides results in persistent phosphorylation of tau protein at Thr181 and Thr231.1951466-68-4 Purity Mol. Pharmacol. 1999, 55, 632?41. 134. Rahman, A.; Grundke-Iqbal, I.; Iqbal, K. PP2B isolated from human brain preferentially dephosphorylates Ser-262 and Ser-396 from the Alzheimer disease abnormally hyperphosphorylated tau. J. Neural Transm. 2006, 113, 219?30. 135. Qian, W.; Yin, X.; Hu, W.; Sh, J.; Gu, J.; Grundke-Iqbal, I.; Iqbal, K.; Gong, C.X.; Liu, F. Activation of protein phosphatase 2B and hyperphosphorylation of Tau in Alzheimer’s disease. J. Alzheimers Dis. 2011, 23, 617?27. 136. Kim, Y.; Lee, Y.I.; Search engine marketing, M.; Kim, S.Y.; Lee, J.E.; Youn, H.D.; Kim, Y.S.; Juhnn, Y.S. Calcineurin dephosphorylates glycogen synthase kinase-3 beta at serine-9 in neuroblast-derived cells. J. Neurochem. 2009, 111, 344?54. 137. Iqbal, K.; Alonso, A.C.; Chen, S.; Chohan, M.O.; El-Akkad, E.; Gong, C.X., Khatoon, S.PMID:33555166 ; Li, B.; Liu, F.; Rahman, A.; et al. Tau pathology in Alzheimer illness as well as other tauopathies. Biochim. Biophys. Acta 2005, 1739, 198?ten. 138. Landrieu, I.; Smet-Nocca, C.; Amniai, L.; Louis, J.V.; Wieruszeski, J.M.; Goris, J.; Janssens, V.; Lippens, G. Molecular implication of PP2A and Pin1 in the Alzheimer’s disease precise hyperphosphorylation of Tau. PLoS 1 2011, 6, e21521. 139. Merrick, S.E.; Demoise, D.C.; Lee, V.M. Site-specific dephosphorylation of tau protein at Ser202/Thr205 in response to microtubule depolymerization in cultured human neurons includes protein phosphatase 2A. J. Biol. Chem. 1996, 271, 5589?594. 140. Sontag, J.M.; Nunbhakdi-Craig, V.; White, C.L., 3rd; Halpain, S.; Sontag, E. The protein phosphatase PP2A/Balpha binds for the microtubule-associated proteins Tau and MAP2 at a motif also recognized by the kinase Fyn: Implications for tauopathies. J. Biol. Chem. 2012, 287, 14984?4993.Int. J. Mol. Sci. 2014,141. Tanimukai, H.; Grundke-Iqbal, I.; Iqbal, K. Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer’s illness. Am. J. Pathol. 2005, 166, 1761?771. 142. Gharbi-Ayachi, A.; Labbe, J.C.; Burgess, A.; Vigneron, S.; Strub, J.M.; Brioudes, E.; van-Dorsselaer, A.; Castro, A.; Lorca, T. The substrate of Greatwall kinase, Arpp 19, controls mitosis by inhibiting protein phosphatase 2A.
